Your browser doesn't support javascript.
Hemophagocytic Lymphohistiocytosis Following COVID-19 Infection.
Molina, Guarina; Contreras, Rafael; Coombes, Kyle; Walgamage, Thilini; Perozo, Maria A; DesBiens, Martha T.
  • Molina G; Internal Medicine, Danbury Hospital, Danbury, USA.
  • Contreras R; Internal Medicine, Danbury Hospital, Danbury, USA.
  • Coombes K; School of Medicine, American University of the Caribbean, Cupecoy, SXM.
  • Walgamage T; Internal Medicine, Danbury Hospital, Danbury, USA.
  • Perozo MA; Internal Medicine, Danbury Hospital, Danbury, USA.
  • DesBiens MT; Infectious Disease, Danbury Hospital, Danbury, USA.
Cureus ; 15(1): e34307, 2023 Jan.
Article in English | MEDLINE | ID: covidwho-2226185
ABSTRACT
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been associated with multiple inflammatory symptoms involving several organ systems, including hematologic manifestations. Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening syndrome caused by excessive inflammation in the absence of immune regulation. We present the case of a patient with HLH secondary to dysregulated inflammatory response following COVID-19; we also describe the diagnostic and management challenges associated with the condition.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report Language: English Journal: Cureus Year: 2023 Document Type: Article Affiliation country: Cureus.34307

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report Language: English Journal: Cureus Year: 2023 Document Type: Article Affiliation country: Cureus.34307